Navigation Links
Guardian of genome predicts treatment outcomes for childhood cancer
Date:11/5/2007

Researchers have identified a new role for a cancer-prevention gene in the response to drug treatment for childhood cancer.

In humans, the p53 tumour suppressor gene, also known as the guardian of the genome, is known for its role in the prevention of cancer. Mutations in the gene are associated with a high incidence of cancer due to the uncontrolled division of cells which give rise to tumours.

In childhood cancers such as neuroblastoma, p53 mutations are rare at diagnosis, however they can emerge after chemotherapy.

A recent study published in the international journal Cancer Research this month by researchers from the Childrens Cancer Institute Australia for Medical Research (CCIA), and collaborators in the USA, describes a new role for p53 in childhood cancer.

The group showed that by inactivating p53 in neuroblastoma cells, the most common childhood cancer, the cancer cells became resistant to a number of chemotherapy drugs.

Our results provide definitive evidence of a role for p53 as a gene which dictates drug sensitivity in neuroblastoma, said Dr Xue of CCIAs Molecular Diagnostics Program.

These results highlight the importance of p53 status as an indicator of a patients treatment response in neuroblastoma.

Further research has found that p53 does not have one defined function in cancer susceptibility to treatment, adds Dr Xue. In some cancer cell types it does not act as a drug sensitivity gene. It is therefore important to assess the clinical effect of p53 mutations in different cancers in a tissue context.


'/>"/>

Contact: Pearly Harumal
pharumal@ccia.org.au
61-299-625-663
Research Australia
Source:Eurekalert

Page: 1

Related medicine news :

1. Guardians Dental Network Experiences Double-Digit Growth
2. Guardian Introduces New Program to Help Employers Control Health Care Premiums
3. One Species Genome Found Within Another
4. Genome Area Linked to Rheumatoid Arthritis
5. Researchers provide genetic associations from a genome-wide scan for cardiovascular disease traits
6. Scientists Map Elephantiasis Parasites Genome
7. Scientists Map Intestinal Bugs Genome
8. Hopkins researchers release genome data on autism
9. Baylor College of Medicine increases fleet of Roche Genome Sequencer FLX Systems to 10 instruments
10. Cats Genome Map Purrfected
11. Domestic cat genome sequenced
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/7/2016)... Texas (PRWEB) , ... February 07, 2016 , ... ... new MyDecision™ program. MyDecision™ empowers employers and organizations with the tools and information ... MyDecision™ combines three elements to cut the cost of providing employee healthcare benefits ...
(Date:2/6/2016)... ... February 06, 2016 , ... ... ADVISORY: 5000 PERIOPERATIVE NURSES EXPECTED AT AORN SURGICAL CONFERENCE & EXPO , ... the world with an estimated 5000 perioperative nurses in attendance to study ...
(Date:2/6/2016)... ... ... With the FCPX LUT: Summer pack from Pixel Film Studios, ... is a Lookup Table that contains a mathematical formula for modifying an image. The ... manipulating each pixel, LUT's can change each color range differently, it gives the user ...
(Date:2/6/2016)... , ... February 06, 2016 , ... ... of eating disorder treatment helps to reduce the frequency and level of relapse. ... Recovery Phase: Re-Establishing Healthy Identity and Purpose,” will explore the critical tasks of ...
(Date:2/5/2016)... ... February 05, 2016 , ... Love is in the air ... variety of colors, assortments and packaging. This staple for Valentine’s Day is a must-have, ... , For Valentine’s Day, not only are long-stem roses available, but also other ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... 4, 2016  Omnicell, Inc. (NASDAQ: OMCL ), a ... healthcare systems, today announced results for its fiscal year ... --> --> GAAP results: Revenue for ... $5.1 million or 4.1% from the third quarter of ... fourth quarter of 2014. Revenue for the year ended ...
(Date:2/4/2016)... 2016  Aethlon Medical, Inc. (Nasdaq: AEMD ... to treat life-threatening diseases, today announced results for ... 31, 2015. --> ... in our last quarterly call, we strategically advanced ... objective to establish the Aethlon Hemopurifier® as a ...
(Date:2/4/2016)... 4, 2016  AMRI (NASDAQ:  AMRI) today announced that ... and President of Pfizer Global Supply, has been elected to ... 2016. In addition, the Company announced that Mr. Gabe ... since 2010, has retired from the AMRI Board of Directors ... other business ventures.  William S. Marth , ...
Breaking Medicine Technology: